FDA clears blood test to aid evaluation for Alzheimer's disease

发生了什么

The blood-based biomarker test is based on technology developed at WashU Medicine by Randall Bateman, MD, and David Holtzman, MD.

摘要按规则整理自下方来源原文

来源